Brian M Slomovitz

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. ncbi Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome
    Kathleen M Schmeler
    Department of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77230-1439, USA
    N Engl J Med 354:261-9. 2006
  2. ncbi Are women ready for the HPV vaccine?
    Brian M Slomovitz
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Gynecol Oncol 103:151-4. 2006
  3. ncbi Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations
    Kathleen M Schmeler
    Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77230, USA
    Obstet Gynecol 108:515-20. 2006
  4. ncbi Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
    Pamela T Soliman
    Department of Gynecologic Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 23:9344-50. 2005
  5. ncbi Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneum
    Pedro T Ramirez
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77230 1439, USA
    Gynecol Oncol 110:56-9. 2008
  6. ncbi A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma
    Brian M Slomovitz
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 116:5415-9. 2010
  7. ncbi Imatinib mesylate (gleevec)--targeted kinases are expressed in uterine sarcomas
    Jimmy J Caudell
    Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA
    Appl Immunohistochem Mol Morphol 13:167-70. 2005
  8. ncbi Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer
    Pedro T Ramirez
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, PO Box 301439, Unit 1362, Houston, TX 77230 1439, USA
    Gynecol Oncol 103:888-90. 2006
  9. ncbi Comparison of total laparoscopic and abdominal radical hysterectomy for patients with early-stage cervical cancer
    Michael Frumovitz
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Obstet Gynecol 110:96-102. 2007
  10. ncbi Endometrial cancer in young, normal-weight women
    Kathleen M Schmeler
    Department of Gynecologic Oncology, The University of Texas, M.D. Anderson Cancer Center, PO Box 301439, Unit 1362, Houston, TX 77230-1439, USA
    Gynecol Oncol 99:388-92. 2005

Detail Information

Publications32

  1. ncbi Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome
    Kathleen M Schmeler
    Department of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77230-1439, USA
    N Engl J Med 354:261-9. 2006
    ..CONCLUSIONS: These findings suggest that prophylactic hysterectomy with bilateral salpingo-oophorectomy is an effective strategy for preventing endometrial and ovarian cancer in women with the Lynch syndrome...
  2. ncbi Are women ready for the HPV vaccine?
    Brian M Slomovitz
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Gynecol Oncol 103:151-4. 2006
    ..Because vaccination for both boys and girls will be critical to reduce the incidence of this disease, we evaluated the willingness of women to accept the HPV vaccine and to consent to having their children vaccinated...
  3. ncbi Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations
    Kathleen M Schmeler
    Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77230, USA
    Obstet Gynecol 108:515-20. 2006
    ..A short time interval was noted from the time of receiving positive genetic test results to undergoing prophylactic surgery...
  4. ncbi Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
    Pamela T Soliman
    Department of Gynecologic Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 23:9344-50. 2005
    ..The purpose of our study was to determine the likelihood of MMR defects (MSH2, MSH6, MLH1) in women with synchronous endometrial and ovarian cancer...
  5. ncbi Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneum
    Pedro T Ramirez
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77230 1439, USA
    Gynecol Oncol 110:56-9. 2008
    ..To evaluate the efficacy and safety of letrozole in patients with recurrent platinum- and taxane-resistant estrogen receptor-positive (ER+) high-grade cancer of the ovary or peritoneum...
  6. ncbi A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma
    Brian M Slomovitz
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 116:5415-9. 2010
    ..Loss of PTEN or activation of PIK3CA results in constitutive activation of AKT, which leads to up-regulation of mammalian target of rapamycin (mTOR). Everolimus is an oral rapamycin analog that acts by selectively inhibiting mTOR...
  7. ncbi Imatinib mesylate (gleevec)--targeted kinases are expressed in uterine sarcomas
    Jimmy J Caudell
    Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA
    Appl Immunohistochem Mol Morphol 13:167-70. 2005
    ..These results indicate that many uterine sarcomas express 1 or more of the kinases targeted by imatinib mesylate and that further investigation of imatinib as a therapy for uterine sarcomas is warranted...
  8. ncbi Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer
    Pedro T Ramirez
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, PO Box 301439, Unit 1362, Houston, TX 77230 1439, USA
    Gynecol Oncol 103:888-90. 2006
    ..To determine whether appendectomy is warranted in patients with apparent early-stage ovarian cancer who undergo surgery for staging and cytoreduction and to determine the complication rate associated with appendectomy in such patients...
  9. ncbi Comparison of total laparoscopic and abdominal radical hysterectomy for patients with early-stage cervical cancer
    Michael Frumovitz
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Obstet Gynecol 110:96-102. 2007
    ..To compare intraoperative, pathologic, and postoperative outcomes of total laparoscopic radical hysterectomy with abdominal radical hysterectomy and pelvic lymphadenectomy for women with early-stage cervical cancer...
  10. ncbi Endometrial cancer in young, normal-weight women
    Kathleen M Schmeler
    Department of Gynecologic Oncology, The University of Texas, M.D. Anderson Cancer Center, PO Box 301439, Unit 1362, Houston, TX 77230-1439, USA
    Gynecol Oncol 99:388-92. 2005
    ..This suggests that hormonal factors, and possibly polycystic ovarian syndrome (PCOS), may contribute to the development of endometrial cancer in young normal-weight women...
  11. ncbi Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma
    Karen H Lu
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Smithville, Texas 78957, USA
    Clin Cancer Res 14:2543-50. 2008
    ....
  12. ncbi Risk factors for young premenopausal women with endometrial cancer
    Pamela T Soliman
    Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
    Obstet Gynecol 105:575-80. 2005
    ..In addition, we found a high incidence of synchronous primary ovarian cancers in this cohort of young, premenopausal women...
  13. ncbi Expression of imatinib mesylate-targeted kinases in endometrial carcinoma
    Brian M Slomovitz
    Department of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030-4009, USA
    Gynecol Oncol 95:32-6. 2004
    ..This preclinical data suggest that imatinib mesylate may be useful in the treatment of patients with endometrial carcinoma...
  14. ncbi Supracervical hysterectomy in patients with advanced epithelial ovarian cancer
    Michael R Milam
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Obstet Gynecol 109:641-6. 2007
    ..To assess whether supracervical hysterectomy (SCH) is a reasonable alternative to total abdominal hysterectomy in patients with advanced ovarian cancer...
  15. ncbi Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases
    Pamela T Soliman
    Department of Gynecologic Oncology, University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA
    Gynecol Oncol 94:456-62. 2004
    ..Patients with concordant endometrioid tumors of the endometrium and ovary had a favorable prognosis, with median survival approaching 10 years...
  16. ncbi Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer
    Michael Frumovitz
    Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    J Am Coll Surg 199:388-93. 2004
    ..Until better markers of lymphatic spread exist, we recommend complete surgical staging of all patients with endometrial cancer...
  17. ncbi Association between adiponectin, insulin resistance, and endometrial cancer
    Pamela T Soliman
    Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77230-1439, USA
    Cancer 106:2376-81. 2006
    ..Women with endometrial cancer were more likely to have low adiponectin levels than controls, even after adjusting for body mass index. This suggested that insulin resistance is independently associated with endometrial cancer...
  18. ncbi Total laparoscopic radical hysterectomy and lymphadenectomy: the M. D. Anderson Cancer Center experience
    Pedro T Ramirez
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, PO Box 301439, Unit 1362, Houston, TX 77230 1439, USA
    Gynecol Oncol 102:252-5. 2006
    ..To retrospectively evaluate the feasibility and morbidity of total laparoscopic radical hysterectomy and lymphadenectomy...
  19. ncbi Electrothermal bipolar coagulation for pelvic exenterations
    Brian M Slomovitz
    Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, 1155 Pressler Boulevard, Unit 1362, Houston, TX 77030, USA
    Gynecol Oncol 102:534-6. 2006
    ..CONCLUSIONS: Use of the electrothermal bipolar coagulator device during pelvic exenteration is safe and may decrease blood loss and the number of units of blood that must be transfused intraoperatively...
  20. ncbi Reduced progression of endometrial hyperplasia with oral mTOR inhibition in the Pten heterozygote murine model
    Michael R Milam
    Department of Gynecologic Oncology, M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Obstet Gynecol 196:247.e1-5. 2007
    ..The objective of this study was to evaluate an oral mTOR inhibitor (mTOR-I) on the reduction of endometrial hyperplasia in an animal model...
  21. ncbi Practice patterns of SGO members for stage IIIA endometrial cancer
    Christine M Lee
    Department of Gynecologic Oncology, Division of Surgery, Unit 440, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA
    Gynecol Oncol 98:77-83. 2005
    ..Histology and grade of the tumor are predictors of therapy recommendations over malignant cytology. Most respondents agreed that patients with malignant cytology should remain in stage IIIA...
  22. ncbi Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
    Brian M Slomovitz
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Obstet Gynecol 104:255-60. 2004
    ..The purpose of this study was to estimate whether a history of tamoxifen use is a prognostic factor for such patients...
  23. ncbi Serous adenocarcinoma of the inguinal region arising from endometriosis followed by a successful pregnancy
    Brian M Slomovitz
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, NY 10021, USA
    Gynecol Oncol 87:152-4. 2002
    ..Inguinal serous carcinoma arising from endometriosis is an unusual cancer. It is uncertain how patients with these tumors should be managed, especially those patients who desire future fertility...
  24. ncbi Her-2/neu overexpression and amplification in uterine papillary serous carcinoma
    Brian M Slomovitz
    Department of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 440, Houston, TX 77030-4009, USA
    J Clin Oncol 22:3126-32. 2004
    ..Overexpression of Her-2/neu was associated with a worse overall prognosis. The use of trastuzumab (Herceptin; Genentech, South San Francisco, CA) in women with UPSC should be further evaluated in a clinical trial setting...
  25. ncbi Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas
    Weiguo Wu
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Cancer Res 63:6195-9. 2003
    ..However, in UPSC/CCC, cdc25B is highly expressed without coordinate increase in phosphorylated ER-alpha. Cdc25B may play important roles in the development and progression of EEC and UPSC/CCC by different mechanisms...
  26. ncbi The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
    Brian M Slomovitz
    Authors Affiliations Morristown Medical Center, Women s Cancer Center, Morristown, New Jersey and MD Anderson Cancer Center, Department of Gynecologic Oncology, University of Texas, Houston, Texas
    Clin Cancer Res 18:5856-64. 2012
    ..Clinical validation of these findings is ongoing. Clin Cancer Res; 18(21); 5856-64. ©2012 AACR...
  27. ncbi Methemoglobinemia induced by topical vaginal sulfanilamide cream in a patient with cervical cancer: a case report
    Ian Bristol
    Department of Radiation Oncology, Unit 97, U.T. M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Gynecol Oncol 97:953-6. 2005
    ....
  28. ncbi Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases
    Brian M Slomovitz
    Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Gynecol Oncol 91:463-9. 2003
    ..Among patients with noninvasive uterine disease, there was a high proportion with abdominal metastasis. Therefore, complete surgical staging of these patients is vital in determining their prognosis...
  29. ncbi Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia
    Jennifer M Rubatt
    Department of Obstetrics and Gynecology, VCUMC Medical College of Virginia, VA 23287, USA
    Gynecol Oncol 99:472-6. 2005
    ..In a woman with a biopsy diagnosis of endometrial hyperplasia, evaluation of MLH1 protein status by immunohistochemistry may provide useful information when medical management is being considered...
  30. ncbi A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component
    Brian M Slomovitz
    Department of Obstetrics and Gynecology, New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, New York, USA
    Am J Surg Pathol 26:592-600. 2002
    ..Stage I MSBTs demonstrate clinical features that are similar to low-stage SBTs. Focal micropapillary architecture (<5 mm) has no bearing on outcome. MSBTs in the general population are not strongly associated with invasive implants...
  31. ncbi Retroperitoneal lymph node resection in patients with cervical cancer
    Israel Zighelboim
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology Washington University School of Medicine and Alvin J. Siteman Cancer Center, St. Louis, MO, USA
    Surg Oncol 15:79-83. 2006
    ..002). CONCLUSIONS: The ability to completely resect suspected metastatic lymph nodes at the time of extraperitoneal lymph node dissection in patients with cervical cancer is associated with size and location of largest lymph node...
  32. ncbi Ovarian mucinous cystadenocarcinoma with virilization
    Farr Nezhat
    Department of Pathology, Mount Sinai Medical Center, New York, New York 10029, USA
    Gynecol Oncol 84:468-72. 2002
    ..Abnormal hormone values normalized 10 days postoperatively. CONCLUSION: We report a rare case of mucinous cystadenocarcinoma with virilization, review the literature, and discuss the mechanisms of hormone production by these tumors...